Skip to Content
U.S. National Institutes of Health
Last Updated: 03/05/10

Clinical Tumor Marker Study Publications Guidelines

REporting recommendations for tumor MARKer prognostic studies (REMARK)

The CDP’s Program for the Assessment of Clinical Cancer Tests (PACCT) and an international collaboration have developed guidelines to begin a dialog about the information that should be included in all publications about tumor markers. The guidelines have been published to encourage comments from the research community and from members of journal editorial boards (http://cancerdiagnosis.nci.nih.gov/assessment/progress/remark.htm ).

See more: Program for the Assessment of Clinical Cancer Tests (PACCT)